This invention provides a matrix composition for sustained drug delivery which is comprised
of an active agent, a hydrophilic polymer and an enteric polymer. The enteric polymer is …

A solid matrix composition which is solid at ambient temperature, which comprises a
viscogenic agent, such as an acrylic acid polymer, capable of developing viscosity on …

(57) ABSTRACT A Solid matrix composition which is Solid at ambient temperature, which
comprises a Viscogenic agent, Such as an acrylic acid polymer, capable of developing …

57 ABSTRACT A solid matrix composition which is solid at ambient tem perature, which
comprises a viscogenic agent, such as an acrylic acid polymer, capable of developing …

Methods for reducing flushing in individuals being treated for hyperlipidemia with nicotinic
acid are disclosed. According to the methods of the present invention, flushing can be …

(51) Int. Cl."........................................................ A61F 2/02 57 ABSTRACT 52 US
Cl........................... 523/113; 525/411; 525/415; Blends of polymers having properties distinct …

A chewable cold/sinus preparation comprising a bitter tasting mixture of a decongestant
such as pseudoephedrine and an antihistamine such as diphenhydramine and/or …

US6129930A - Methods and sustained release nicotinic acid compositions for treating
hyperlipidemia at night - Google Patents US6129930A - Methods and sustained release …

US PATENT DOCUMENTS 5,919,828 A 7/1999 Weglicki 5,932,572 A 8/1999 Dean et al.
5,700,410 A 12/1997 Nakamichi et al. 5,945,125 A 8/1999 Kim 5,773,023 A 6/1998 Deckner …

An orally administered antihyperlipidemia composition according to the present invention
includes from about 250 to about 3000 parts by weight of nicotinic acid, and from about 5 to …